Rank | Gene Set | Z-score |
---|---|---|
1 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 7.64224838 |
2 | modulation by symbiont of host immune response (GO:0052553) | 7.64224838 |
3 | positive regulation by symbiont of host defense response (GO:0052509) | 7.64224838 |
4 | modulation by symbiont of host defense response (GO:0052031) | 7.64224838 |
5 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 7.64224838 |
6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 7.64224838 |
7 | regulation of interferon-beta biosynthetic process (GO:0045357) | 6.68252281 |
8 | macrophage activation involved in immune response (GO:0002281) | 5.81333026 |
9 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 5.55603121 |
10 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.54217573 |
11 | oligosaccharide catabolic process (GO:0009313) | 5.21087871 |
12 | positive regulation of interferon-alpha production (GO:0032727) | 5.03028893 |
13 | neutrophil activation involved in immune response (GO:0002283) | 4.98070500 |
14 | glycolipid catabolic process (GO:0019377) | 4.95357648 |
15 | response to host immune response (GO:0052572) | 4.93494425 |
16 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.93494425 |
17 | negative regulation of interleukin-12 production (GO:0032695) | 4.84576972 |
18 | microglial cell activation (GO:0001774) | 4.83570008 |
19 | regulation of interferon-alpha production (GO:0032647) | 4.79766853 |
20 | amino sugar catabolic process (GO:0046348) | 4.57715961 |
21 | response to host (GO:0075136) | 4.41843085 |
22 | response to host defenses (GO:0052200) | 4.41843085 |
23 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.41843085 |
24 | ceramide catabolic process (GO:0046514) | 4.38975380 |
25 | macrophage activation (GO:0042116) | 4.19306791 |
26 | regulation of mononuclear cell migration (GO:0071675) | 4.15308323 |
27 | immunoglobulin mediated immune response (GO:0016064) | 3.91389589 |
28 | response to peptidoglycan (GO:0032494) | 3.89513662 |
29 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.84354580 |
30 | membrane lipid catabolic process (GO:0046466) | 3.83710875 |
31 | barbed-end actin filament capping (GO:0051016) | 3.82831112 |
32 | myeloid cell activation involved in immune response (GO:0002275) | 3.78627296 |
33 | positive regulation of antigen processing and presentation (GO:0002579) | 3.75832091 |
34 | respiratory burst (GO:0045730) | 3.73893168 |
35 | virion attachment to host cell (GO:0019062) | 3.73852019 |
36 | adhesion of symbiont to host cell (GO:0044650) | 3.73852019 |
37 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.72080743 |
38 | sphingolipid catabolic process (GO:0030149) | 3.68233431 |
39 | regulation of cholesterol storage (GO:0010885) | 3.67650102 |
40 | N-acetylneuraminate metabolic process (GO:0006054) | 3.67593056 |
41 | pinocytosis (GO:0006907) | 3.67243987 |
42 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.65187561 |
43 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.62780267 |
44 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.53528451 |
45 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.52475072 |
46 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.50901893 |
47 | T-helper 1 type immune response (GO:0042088) | 3.47205843 |
48 | detection of molecule of bacterial origin (GO:0032490) | 3.45730626 |
49 | I-kappaB phosphorylation (GO:0007252) | 3.44066074 |
50 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.43883249 |
51 | protein localization to endosome (GO:0036010) | 3.42686924 |
52 | positive regulation of interferon-beta production (GO:0032728) | 3.40872032 |
53 | * cellular response to thyroid hormone stimulus (GO:0097067) | 3.40675340 |
54 | myeloid dendritic cell differentiation (GO:0043011) | 3.32328166 |
55 | adhesion of symbiont to host (GO:0044406) | 3.32136097 |
56 | apoptotic cell clearance (GO:0043277) | 3.31364218 |
57 | low-density lipoprotein particle clearance (GO:0034383) | 3.26953216 |
58 | monocyte chemotaxis (GO:0002548) | 3.25955371 |
59 | positive regulation of mast cell activation (GO:0033005) | 3.25684625 |
60 | positive regulation of macrophage cytokine production (GO:0060907) | 3.20590643 |
61 | phagosome maturation (GO:0090382) | 3.18046626 |
62 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 3.17119925 |
63 | granulocyte activation (GO:0036230) | 3.15476969 |
64 | regulation of monocyte chemotaxis (GO:0090025) | 3.15249245 |
65 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.13406045 |
66 | negative regulation of mast cell activation (GO:0033004) | 3.12994252 |
67 | negative regulation of interleukin-17 production (GO:0032700) | 3.12939929 |
68 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.11112689 |
69 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.09365816 |
70 | regulation of podosome assembly (GO:0071801) | 3.09016881 |
71 | regulation of antigen processing and presentation (GO:0002577) | 3.07831743 |
72 | neutrophil activation (GO:0042119) | 3.02573621 |
73 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.01245208 |
74 | keratan sulfate catabolic process (GO:0042340) | 3.00389997 |
75 | positive regulation of leukocyte degranulation (GO:0043302) | 3.00387567 |
76 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.00291847 |
77 | NIK/NF-kappaB signaling (GO:0038061) | 2.97622670 |
78 | mannose metabolic process (GO:0006013) | 2.96748993 |
79 | cell adhesion mediated by integrin (GO:0033627) | 2.96470327 |
80 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.94525555 |
81 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.92143608 |
82 | regulation of mast cell degranulation (GO:0043304) | 2.92006512 |
83 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.90223689 |
84 | regulation of macrophage chemotaxis (GO:0010758) | 2.89647207 |
85 | regulation of macrophage cytokine production (GO:0010935) | 2.88796933 |
86 | myeloid dendritic cell activation (GO:0001773) | 2.88524445 |
87 | cellular response to arsenic-containing substance (GO:0071243) | 2.86637168 |
88 | positive regulation of cholesterol efflux (GO:0010875) | 2.84285044 |
89 | response to lipoprotein particle (GO:0055094) | 2.83778012 |
90 | macrophage differentiation (GO:0030225) | 2.82741573 |
91 | hyaluronan catabolic process (GO:0030214) | 2.82188718 |
92 | regulation of mast cell activation (GO:0033003) | 2.81666365 |
93 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.81637422 |
94 | cellular extravasation (GO:0045123) | 2.81552584 |
95 | regulation of leukocyte degranulation (GO:0043300) | 2.80449906 |
96 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.79883743 |
97 | * response to thyroid hormone (GO:0097066) | 2.79688609 |
98 | regulation of vitamin metabolic process (GO:0030656) | 2.79230390 |
99 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.79034714 |
100 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.79034714 |
101 | positive regulation of bone resorption (GO:0045780) | 2.78334481 |
102 | positive regulation of bone remodeling (GO:0046852) | 2.78334481 |
103 | lymphocyte chemotaxis (GO:0048247) | 2.77885635 |
104 | cellular response to interferon-alpha (GO:0035457) | 2.77808259 |
105 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.77596216 |
106 | dendritic cell differentiation (GO:0097028) | 2.76946455 |
107 | regulation of chemokine biosynthetic process (GO:0045073) | 2.76109082 |
108 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.75891768 |
109 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.75556069 |
110 | lipoprotein transport (GO:0042953) | 2.74900044 |
111 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.72738087 |
112 | myeloid leukocyte activation (GO:0002274) | 2.71612077 |
113 | negative regulation of lipid storage (GO:0010888) | 2.71138368 |
114 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.70998155 |
115 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.70932241 |
116 | response to interferon-alpha (GO:0035455) | 2.70639058 |
117 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.70455054 |
118 | eosinophil migration (GO:0072677) | 2.68588013 |
119 | glycosphingolipid catabolic process (GO:0046479) | 2.68503295 |
120 | lytic vacuole organization (GO:0080171) | 2.67707588 |
121 | lysosome organization (GO:0007040) | 2.67707588 |
122 | positive regulation of T cell apoptotic process (GO:0070234) | 2.65723160 |
123 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.65101010 |
124 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.64606131 |
125 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.64487110 |
126 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.63329993 |
127 | eosinophil chemotaxis (GO:0048245) | 2.63072072 |
128 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.62366726 |
129 | cellular response to lipopolysaccharide (GO:0071222) | 2.61552796 |
130 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.61511398 |
131 | B cell mediated immunity (GO:0019724) | 2.60315646 |
132 | peptide catabolic process (GO:0043171) | 2.59464630 |
133 | regulation of superoxide anion generation (GO:0032928) | 2.59370314 |
134 | positive regulation of mast cell degranulation (GO:0043306) | 2.58998678 |
135 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.58998678 |
136 | neutrophil mediated immunity (GO:0002446) | 2.58837557 |
137 | detection of external biotic stimulus (GO:0098581) | 2.58164673 |
138 | glial cell migration (GO:0008347) | 2.57204553 |
139 | positive regulation of chemokine production (GO:0032722) | 2.57099208 |
140 | adenosine receptor signaling pathway (GO:0001973) | 2.56946981 |
141 | intracellular pH reduction (GO:0051452) | 2.55712980 |
142 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.55534711 |
143 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.55332430 |
144 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.54394373 |
145 | cellular response to molecule of bacterial origin (GO:0071219) | 2.53251767 |
146 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.53172574 |
147 | positive regulation of extracellular matrix organization (GO:1903055) | 2.52194015 |
148 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.51863689 |
149 | cellular response to type I interferon (GO:0071357) | 2.50862593 |
150 | type I interferon signaling pathway (GO:0060337) | 2.50862593 |
151 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.50648452 |
152 | germinal center formation (GO:0002467) | 2.48992371 |
153 | response to type I interferon (GO:0034340) | 2.48272581 |
154 | negative regulation of interleukin-6 production (GO:0032715) | 2.48209502 |
155 | neutrophil chemotaxis (GO:0030593) | 2.48046257 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.65866819 |
2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.71596520 |
3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.37540455 |
4 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.65788182 |
5 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.35863496 |
6 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 4.18893708 |
7 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.87295095 |
8 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.90355892 |
9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.86534188 |
10 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.83186043 |
11 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.75825622 |
12 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.55478575 |
13 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.49597125 |
14 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.26633461 |
15 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.25121894 |
16 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.21541567 |
17 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 2.15698133 |
18 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.12631891 |
19 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.03135478 |
20 | SPI1_23127762_ChIP-Seq_K562_Human | 2.02472022 |
21 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.01150886 |
22 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.91687546 |
23 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.84135211 |
24 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.78163232 |
25 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.77963991 |
26 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.76246632 |
27 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.69983880 |
28 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.67868746 |
29 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.67392436 |
30 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.66110361 |
31 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.63083051 |
32 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.62269251 |
33 | * TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.61623408 |
34 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.61128547 |
35 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.58267486 |
36 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.55196483 |
37 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.53877586 |
38 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.53751800 |
39 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.53033065 |
40 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.50339320 |
41 | * RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.42634726 |
42 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.40495216 |
43 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.39171763 |
44 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38141287 |
45 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.37711127 |
46 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.37462756 |
47 | GATA1_22025678_ChIP-Seq_K562_Human | 1.36466534 |
48 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36366036 |
49 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.32516730 |
50 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.30483780 |
51 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.30076512 |
52 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.27657765 |
53 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.26043347 |
54 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.24138339 |
55 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.23187343 |
56 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.23125696 |
57 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.23118656 |
58 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.22770840 |
59 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.17427465 |
60 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.15072038 |
61 | MAF_26560356_Chip-Seq_TH1_Human | 1.14329707 |
62 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.13485403 |
63 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.12522109 |
64 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.11756114 |
65 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.11564891 |
66 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.10648762 |
67 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.10318635 |
68 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.09679636 |
69 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.09274965 |
70 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.09274965 |
71 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08514448 |
72 | * MYB_26560356_Chip-Seq_TH2_Human | 1.08355214 |
73 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.08119061 |
74 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.07893998 |
75 | * VDR_21846776_ChIP-Seq_THP-1_Human | 1.06530370 |
76 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.06456209 |
77 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.06039756 |
78 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.05708966 |
79 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05584226 |
80 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.04050989 |
81 | KDM2B_26808549_Chip-Seq_K562_Human | 1.03750893 |
82 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.03153693 |
83 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.02999013 |
84 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.02985029 |
85 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.02300903 |
86 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.02169665 |
87 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.01685666 |
88 | GATA3_26560356_Chip-Seq_TH2_Human | 1.01467569 |
89 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.01413075 |
90 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.00996135 |
91 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.00219933 |
92 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.99782408 |
93 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.98562795 |
94 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.98350155 |
95 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.98319290 |
96 | * CJUN_26792858_Chip-Seq_BT549_Human | 0.97545744 |
97 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95924812 |
98 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.95400219 |
99 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.94564275 |
100 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.93526383 |
101 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.92695707 |
102 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.91009647 |
103 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.90445953 |
104 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90160794 |
105 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.89996124 |
106 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.89365201 |
107 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.88267521 |
108 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.88020366 |
109 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.87978238 |
110 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87451474 |
111 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.87444987 |
112 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.87322730 |
113 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.86593490 |
114 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.85749435 |
115 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.85723788 |
116 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84638821 |
117 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.84629110 |
118 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.84335336 |
119 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.83471919 |
120 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.82769683 |
121 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.82649264 |
122 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.82417059 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005058_abnormal_lysosome_morphology | 5.93111504 |
2 | MP0003172_abnormal_lysosome_physiology | 4.00627390 |
3 | MP0003303_peritoneal_inflammation | 3.83953252 |
4 | MP0006082_CNS_inflammation | 3.39169070 |
5 | MP0001835_abnormal_antigen_presentation | 3.35602455 |
6 | MP0003436_decreased_susceptibility_to | 3.30527540 |
7 | MP0009840_abnormal_foam_cell | 3.16942898 |
8 | MP0002139_abnormal_hepatobiliary_system | 3.08632175 |
9 | MP0002419_abnormal_innate_immunity | 2.89065427 |
10 | MP0003191_abnormal_cellular_cholesterol | 2.65646164 |
11 | MP0003690_abnormal_glial_cell | 2.65536886 |
12 | MP0008438_abnormal_cutaneous_collagen | 2.65444291 |
13 | MP0002148_abnormal_hypersensitivity_rea | 2.36482421 |
14 | * MP0005000_abnormal_immune_tolerance | 2.30613248 |
15 | MP0005257_abnormal_intraocular_pressure | 2.29544017 |
16 | MP0009785_altered_susceptibility_to | 2.17800924 |
17 | MP0001533_abnormal_skeleton_physiology | 2.15539030 |
18 | MP0001790_abnormal_immune_system | 2.09943992 |
19 | MP0005387_immune_system_phenotype | 2.09943992 |
20 | MP0003300_gastrointestinal_ulcer | 2.07958629 |
21 | MP0005025_abnormal_response_to | 2.05471628 |
22 | MP0002452_abnormal_antigen_presenting | 1.99631956 |
23 | MP0005464_abnormal_platelet_physiology | 1.99531313 |
24 | MP0003724_increased_susceptibility_to | 1.98692289 |
25 | * MP0000604_amyloidosis | 1.96803044 |
26 | MP0004510_myositis | 1.96559374 |
27 | MP0005451_abnormal_body_composition | 1.93979757 |
28 | MP0000569_abnormal_digit_pigmentation | 1.87751178 |
29 | MP0000343_altered_response_to | 1.87045225 |
30 | MP0003075_altered_response_to | 1.79964986 |
31 | MP0002723_abnormal_immune_serum | 1.71546500 |
32 | MP0001800_abnormal_humoral_immune | 1.64885080 |
33 | MP0002998_abnormal_bone_remodeling | 1.61895013 |
34 | MP0004947_skin_inflammation | 1.61092712 |
35 | MP0003453_abnormal_keratinocyte_physiol | 1.58341645 |
36 | MP0003806_abnormal_nucleotide_metabolis | 1.56501216 |
37 | MP0000685_abnormal_immune_system | 1.54036427 |
38 | MP0001819_abnormal_immune_cell | 1.53218793 |
39 | MP0003183_abnormal_peptide_metabolism | 1.52077859 |
40 | MP0002420_abnormal_adaptive_immunity | 1.51312457 |
41 | * MP0003448_altered_tumor_morphology | 1.51007548 |
42 | MP0001958_emphysema | 1.50758984 |
43 | MP0003566_abnormal_cell_adhesion | 1.49493863 |
44 | MP0003705_abnormal_hypodermis_morpholog | 1.47777155 |
45 | MP0008469_abnormal_protein_level | 1.47503330 |
46 | * MP0001845_abnormal_inflammatory_respons | 1.46304044 |
47 | MP0005167_abnormal_blood-brain_barrier | 1.44260531 |
48 | MP0005166_decreased_susceptibility_to | 1.43121428 |
49 | MP0002877_abnormal_melanocyte_morpholog | 1.42264121 |
50 | MP0005671_abnormal_response_to | 1.39759830 |
51 | MP0004858_abnormal_nervous_system | 1.38244022 |
52 | MP0002405_respiratory_system_inflammati | 1.37845133 |
53 | MP0009764_decreased_sensitivity_to | 1.36346397 |
54 | MP0003279_aneurysm | 1.33865542 |
55 | MP0002090_abnormal_vision | 1.33013665 |
56 | MP0003656_abnormal_erythrocyte_physiolo | 1.31110093 |
57 | MP0005164_abnormal_response_to | 1.23434863 |
58 | MP0008004_abnormal_stomach_pH | 1.20016607 |
59 | MP0009278_abnormal_bone_marrow | 1.17426895 |
60 | MP0005365_abnormal_bile_salt | 1.15873268 |
61 | MP0004130_abnormal_muscle_cell | 1.13975549 |
62 | MP0001542_abnormal_bone_strength | 1.10898887 |
63 | MP0010386_abnormal_urinary_bladder | 1.10241462 |
64 | MP0002254_reproductive_system_inflammat | 1.06675045 |
65 | MP0000465_gastrointestinal_hemorrhage | 1.03879841 |
66 | MP0000920_abnormal_myelination | 1.03674401 |
67 | MP0005390_skeleton_phenotype | 1.03167352 |
68 | MP0001851_eye_inflammation | 0.99254219 |
69 | MP0000716_abnormal_immune_system | 0.98778113 |
70 | MP0005083_abnormal_biliary_tract | 0.97925533 |
71 | MP0003195_calcinosis | 0.97848291 |
72 | MP0002933_joint_inflammation | 0.97075240 |
73 | MP0000689_abnormal_spleen_morphology | 0.97013332 |
74 | MP0010155_abnormal_intestine_physiology | 0.94467083 |
75 | MP0001849_ear_inflammation | 0.93457277 |
76 | MP0004883_abnormal_blood_vessel | 0.93281295 |
77 | MP0001853_heart_inflammation | 0.90491521 |
78 | MP0000249_abnormal_blood_vessel | 0.89530168 |
79 | MP0005595_abnormal_vascular_smooth | 0.87611383 |
80 | * MP0003634_abnormal_glial_cell | 0.86655263 |
81 | MP0003091_abnormal_cell_migration | 0.86329964 |
82 | MP0003828_pulmonary_edema | 0.86248368 |
83 | MP0005275_abnormal_skin_tensile | 0.85859358 |
84 | MP0003329_amyloid_beta_deposits | 0.84414575 |
85 | MP0009333_abnormal_splenocyte_physiolog | 0.82828699 |
86 | MP0005197_abnormal_uvea_morphology | 0.82590798 |
87 | MP0002896_abnormal_bone_mineralization | 0.82547700 |
88 | MP0003795_abnormal_bone_structure | 0.82528639 |
89 | MP0004782_abnormal_surfactant_physiolog | 0.82258521 |
90 | MP0005174_abnormal_tail_pigmentation | 0.79351680 |
91 | MP0009763_increased_sensitivity_to | 0.79022291 |
92 | MP0010329_abnormal_lipoprotein_level | 0.78960097 |
93 | MP0002429_abnormal_blood_cell | 0.78539113 |
94 | MP0002398_abnormal_bone_marrow | 0.75357806 |
95 | MP0002277_abnormal_respiratory_mucosa | 0.74564024 |
96 | MP0000371_diluted_coat_color | 0.74459439 |
97 | * MP0005310_abnormal_salivary_gland | 0.74155685 |
98 | MP0000609_abnormal_liver_physiology | 0.73966425 |
99 | MP0002136_abnormal_kidney_physiology | 0.73768762 |
100 | * MP0000858_altered_metastatic_potential | 0.73575685 |
101 | MP0002722_abnormal_immune_system | 0.72752262 |
102 | MP0001756_abnormal_urination | 0.70013743 |
103 | MP0002837_dystrophic_cardiac_calcinosis | 0.69622725 |
104 | MP0001545_abnormal_hematopoietic_system | 0.69496990 |
105 | MP0005397_hematopoietic_system_phenotyp | 0.69496990 |
106 | MP0008260_abnormal_autophagy | 0.69468637 |
107 | MP0000767_abnormal_smooth_muscle | 0.68759412 |
108 | MP0005165_increased_susceptibility_to | 0.67981190 |
109 | MP0005023_abnormal_wound_healing | 0.67645644 |
110 | MP0002138_abnormal_hepatobiliary_system | 0.66650551 |
111 | MP0008874_decreased_physiological_sensi | 0.65516518 |
112 | MP0002166_altered_tumor_susceptibility | 0.62889164 |
113 | MP0003633_abnormal_nervous_system | 0.62839279 |
114 | MP0005647_abnormal_sex_gland | 0.62454187 |
115 | MP0002332_abnormal_exercise_endurance | 0.61816685 |
116 | MP0006054_spinal_hemorrhage | 0.61419843 |
117 | MP0001663_abnormal_digestive_system | 0.61342364 |
118 | MP0004019_abnormal_vitamin_homeostasis | 0.60993776 |
119 | MP0009643_abnormal_urine_homeostasis | 0.60940584 |
120 | MP0003186_abnormal_redox_activity | 0.60595677 |
121 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.60366137 |
122 | MP0005319_abnormal_enzyme/_coenzyme | 0.57792164 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Increased cerebral lipofuscin (HP:0011813) | 7.71054697 |
2 | Vacuolated lymphocytes (HP:0001922) | 6.76321717 |
3 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 6.54202326 |
4 | Dysostosis multiplex (HP:0000943) | 5.61084019 |
5 | Systemic lupus erythematosus (HP:0002725) | 5.60126373 |
6 | Recurrent abscess formation (HP:0002722) | 5.40142322 |
7 | Abnormality of glycolipid metabolism (HP:0010969) | 5.18414107 |
8 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.18414107 |
9 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.18414107 |
10 | Mucopolysacchariduria (HP:0008155) | 4.74623773 |
11 | Urinary glycosaminoglycan excretion (HP:0003541) | 4.74623773 |
12 | Abnormality of macrophages (HP:0004311) | 4.73513659 |
13 | Eczematoid dermatitis (HP:0000976) | 4.59656510 |
14 | Recurrent bacterial skin infections (HP:0005406) | 4.55616882 |
15 | Disinhibition (HP:0000734) | 4.53040131 |
16 | Axonal loss (HP:0003447) | 4.48628059 |
17 | Abnormality of polysaccharide metabolism (HP:0011012) | 4.48062534 |
18 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 4.48062534 |
19 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 4.48062534 |
20 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.33634334 |
21 | Glomerulonephritis (HP:0000099) | 3.90382288 |
22 | Loss of speech (HP:0002371) | 3.84274487 |
23 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.79985547 |
24 | Nuclear cataract (HP:0100018) | 3.67660037 |
25 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.57872446 |
26 | Myocardial infarction (HP:0001658) | 3.24869127 |
27 | Autoimmune thrombocytopenia (HP:0001973) | 3.03756987 |
28 | Complement deficiency (HP:0004431) | 2.98861795 |
29 | Neuronal loss in central nervous system (HP:0002529) | 2.92231838 |
30 | Asymmetric septal hypertrophy (HP:0001670) | 2.89992145 |
31 | Gingivitis (HP:0000230) | 2.89340908 |
32 | J-shaped sella turcica (HP:0002680) | 2.86962882 |
33 | Upper motor neuron abnormality (HP:0002127) | 2.81392266 |
34 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.80456986 |
35 | Hepatosplenomegaly (HP:0001433) | 2.80358330 |
36 | Agnosia (HP:0010524) | 2.77748510 |
37 | Abnormality of complement system (HP:0005339) | 2.77505911 |
38 | Mutism (HP:0002300) | 2.76633944 |
39 | Purpura (HP:0000979) | 2.75661079 |
40 | Myositis (HP:0100614) | 2.70242313 |
41 | Chronic obstructive pulmonary disease (HP:0006510) | 2.65488818 |
42 | Obstructive lung disease (HP:0006536) | 2.65488818 |
43 | Apathy (HP:0000741) | 2.65427170 |
44 | Diminished motivation (HP:0000745) | 2.64839057 |
45 | Neurofibrillary tangles (HP:0002185) | 2.63598023 |
46 | Orchitis (HP:0100796) | 2.62625336 |
47 | Mediastinal lymphadenopathy (HP:0100721) | 2.59867485 |
48 | Abnormality of the lumbar spine (HP:0100712) | 2.56745330 |
49 | Nephritis (HP:0000123) | 2.54716443 |
50 | Conjunctival telangiectasia (HP:0000524) | 2.54582313 |
51 | Recurrent skin infections (HP:0001581) | 2.54368553 |
52 | Retinal atrophy (HP:0001105) | 2.53105847 |
53 | Metaphyseal irregularity (HP:0003025) | 2.52566851 |
54 | Thick nail (HP:0001805) | 2.46988501 |
55 | Supranuclear gaze palsy (HP:0000605) | 2.44777964 |
56 | Peripheral demyelination (HP:0011096) | 2.44356076 |
57 | Increased serum ferritin (HP:0003281) | 2.43439634 |
58 | Pathologic fracture (HP:0002756) | 2.41298811 |
59 | Global brain atrophy (HP:0002283) | 2.40568230 |
60 | Tetraparesis (HP:0002273) | 2.38272070 |
61 | Inappropriate behavior (HP:0000719) | 2.36105095 |
62 | Basal ganglia calcification (HP:0002135) | 2.34751500 |
63 | Increased CSF protein (HP:0002922) | 2.33135388 |
64 | Dementia (HP:0000726) | 2.28570372 |
65 | Thoracic kyphosis (HP:0002942) | 2.27838832 |
66 | Prolonged neonatal jaundice (HP:0006579) | 2.27625312 |
67 | Personality changes (HP:0000751) | 2.25560172 |
68 | Prostate neoplasm (HP:0100787) | 2.24003840 |
69 | Vertebral compression fractures (HP:0002953) | 2.23357761 |
70 | Osteolytic defects of the hand bones (HP:0009699) | 2.19575869 |
71 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.19575869 |
72 | Progressive neurologic deterioration (HP:0002344) | 2.18860065 |
73 | Ovoid vertebral bodies (HP:0003300) | 2.16779762 |
74 | Interstitial pulmonary disease (HP:0006530) | 2.14598883 |
75 | Stomatitis (HP:0010280) | 2.14290682 |
76 | Retrobulbar optic neuritis (HP:0100654) | 2.13163121 |
77 | Optic neuritis (HP:0100653) | 2.13163121 |
78 | Spondylolisthesis (HP:0003302) | 2.12385835 |
79 | Pustule (HP:0200039) | 2.11970701 |
80 | Hematochezia (HP:0002573) | 2.11901933 |
81 | Progressive visual loss (HP:0000529) | 2.11046967 |
82 | Cerebral inclusion bodies (HP:0100314) | 2.09626652 |
83 | Urticaria (HP:0001025) | 2.08321151 |
84 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.05771851 |
85 | Cardiomegaly (HP:0001640) | 2.03978804 |
86 | Bone pain (HP:0002653) | 2.02684416 |
87 | Petechiae (HP:0000967) | 1.97682645 |
88 | Hypercholesterolemia (HP:0003124) | 1.97636840 |
89 | Periodontitis (HP:0000704) | 1.96507534 |
90 | Arterial tortuosity (HP:0005116) | 1.96001049 |
91 | Osteomyelitis (HP:0002754) | 1.95411715 |
92 | Cerebral aneurysm (HP:0004944) | 1.94311787 |
93 | Cellulitis (HP:0100658) | 1.94033623 |
94 | Cervical subluxation (HP:0003308) | 1.92525054 |
95 | Recurrent fungal infections (HP:0002841) | 1.91068441 |
96 | Xanthomatosis (HP:0000991) | 1.90602181 |
97 | Malnutrition (HP:0004395) | 1.90579998 |
98 | Abnormality of the periventricular white matter (HP:0002518) | 1.89851532 |
99 | Abnormality of iron homeostasis (HP:0011031) | 1.87491480 |
100 | Mucosal telangiectasiae (HP:0100579) | 1.85143293 |
101 | Nausea (HP:0002018) | 1.85070688 |
102 | Pulmonary infiltrates (HP:0002113) | 1.83955376 |
103 | Spontaneous hematomas (HP:0007420) | 1.81248831 |
104 | Protuberant abdomen (HP:0001538) | 1.78102168 |
105 | Vascular tortuosity (HP:0004948) | 1.77206436 |
106 | Frequent falls (HP:0002359) | 1.74683444 |
107 | Abnormality of the nasal mucosa (HP:0000433) | 1.73238200 |
108 | Deformed sella turcica (HP:0002681) | 1.71729492 |
109 | Clumsiness (HP:0002312) | 1.71037813 |
110 | Amyloidosis (HP:0011034) | 1.70541828 |
111 | Joint stiffness (HP:0001387) | 1.70345231 |
112 | Esophageal varix (HP:0002040) | 1.70168714 |
113 | Premature rupture of membranes (HP:0001788) | 1.69600448 |
114 | Bone cyst (HP:0012062) | 1.69152199 |
115 | Polyneuropathy (HP:0001271) | 1.67086613 |
116 | Thin bony cortex (HP:0002753) | 1.62724617 |
117 | Hemoptysis (HP:0002105) | 1.61949307 |
118 | Beaking of vertebral bodies (HP:0004568) | 1.60035712 |
119 | Premature loss of primary teeth (HP:0006323) | 1.59899012 |
120 | Acrocyanosis (HP:0001063) | 1.59005011 |
121 | Neoplasm of head and neck (HP:0012288) | 1.58044592 |
122 | Esophageal neoplasm (HP:0100751) | 1.58044592 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BLK | 3.50883166 |
2 | KIT | 3.46077355 |
3 | RIPK4 | 3.42953459 |
4 | TBK1 | 3.32271459 |
5 | ERN1 | 3.10096772 |
6 | DDR2 | 3.09509964 |
7 | TGFBR2 | 2.94100514 |
8 | TYK2 | 2.89748238 |
9 | TRIB3 | 2.58199177 |
10 | MAP3K14 | 2.49901522 |
11 | TAOK2 | 2.29906920 |
12 | IRAK4 | 2.10208947 |
13 | JAK1 | 1.99246116 |
14 | IRAK3 | 1.97912488 |
15 | NEK9 | 1.97654837 |
16 | SCYL2 | 1.87485122 |
17 | PRPF4B | 1.84015718 |
18 | CAMK1D | 1.82527370 |
19 | CSF1R | 1.78195621 |
20 | TTN | 1.76729748 |
21 | CDC42BPA | 1.72533930 |
22 | ACVR1B | 1.68830156 |
23 | PKN2 | 1.68317648 |
24 | TAOK3 | 1.61333148 |
25 | TAOK1 | 1.61301166 |
26 | IKBKE | 1.60342984 |
27 | CAMKK2 | 1.58691426 |
28 | EPHB1 | 1.56724780 |
29 | MAP4K1 | 1.54355952 |
30 | FES | 1.53466395 |
31 | HCK | 1.43111212 |
32 | ZAP70 | 1.42487473 |
33 | RIPK1 | 1.42205729 |
34 | FGR | 1.37364488 |
35 | IKBKB | 1.37234033 |
36 | CSK | 1.34751880 |
37 | SYK | 1.32280456 |
38 | JAK2 | 1.32042751 |
39 | PBK | 1.31812955 |
40 | PIM2 | 1.29743479 |
41 | JAK3 | 1.26380456 |
42 | MAP2K3 | 1.24120968 |
43 | NME2 | 1.22388577 |
44 | CAMK1G | 1.18831419 |
45 | CAMKK1 | 1.16613182 |
46 | LIMK1 | 1.16350757 |
47 | ADRBK2 | 1.15628542 |
48 | BMX | 1.13520089 |
49 | MAP3K3 | 1.11418696 |
50 | MAP3K13 | 1.09718849 |
51 | LYN | 1.06976907 |
52 | MATK | 1.02398588 |
53 | PTK6 | 1.01506653 |
54 | LCK | 0.99393291 |
55 | ABL2 | 0.94635806 |
56 | EPHB2 | 0.93965794 |
57 | MOS | 0.93779083 |
58 | PAK4 | 0.93558821 |
59 | STK10 | 0.92799200 |
60 | EGFR | 0.91670275 |
61 | GRK7 | 0.90658750 |
62 | KSR2 | 0.87830634 |
63 | LRRK2 | 0.86937940 |
64 | TRPM7 | 0.86731799 |
65 | PDK2 | 0.83579494 |
66 | TGFBR1 | 0.82598515 |
67 | FGFR4 | 0.80929987 |
68 | TESK1 | 0.80599185 |
69 | ITK | 0.75343260 |
70 | FGFR3 | 0.73845980 |
71 | PRKCD | 0.73664150 |
72 | BTK | 0.69291438 |
73 | PLK2 | 0.69237949 |
74 | DAPK2 | 0.68422629 |
75 | ARAF | 0.68251419 |
76 | PRKCH | 0.67549276 |
77 | FYN | 0.66440329 |
78 | ICK | 0.65770624 |
79 | MAP3K11 | 0.65596032 |
80 | PDPK1 | 0.65564482 |
81 | LATS2 | 0.65358233 |
82 | ABL1 | 0.64760842 |
83 | MAP3K1 | 0.64690275 |
84 | TYRO3 | 0.64376181 |
85 | SIK1 | 0.61362508 |
86 | MAP3K2 | 0.61053997 |
87 | RPS6KC1 | 0.58154200 |
88 | RPS6KL1 | 0.58154200 |
89 | MAP2K6 | 0.57019819 |
90 | CHUK | 0.55575520 |
91 | PDGFRB | 0.54854215 |
92 | IRAK2 | 0.54832263 |
93 | PDK1 | 0.53933117 |
94 | CDK6 | 0.53671980 |
95 | KDR | 0.53493461 |
96 | NTRK1 | 0.52009745 |
97 | PTK2B | 0.51205906 |
98 | TXK | 0.50895796 |
99 | MARK3 | 0.50084704 |
100 | SIK2 | 0.50025679 |
101 | PIK3CG | 0.49835350 |
102 | EPHA3 | 0.49730448 |
103 | IGF1R | 0.49443173 |
104 | SRC | 0.49178551 |
105 | RET | 0.48236402 |
106 | RPS6KA2 | 0.46688085 |
107 | RPS6KA4 | 0.45849422 |
108 | DAPK3 | 0.45116273 |
109 | MAPK4 | 0.44020409 |
110 | RPS6KA6 | 0.42738636 |
111 | MAP3K9 | 0.41981958 |
112 | GRK6 | 0.41538918 |
113 | MAP3K5 | 0.41234347 |
114 | BMPR2 | 0.40390369 |
115 | GSK3A | 0.39556466 |
116 | MAPK7 | 0.38752872 |
117 | PDGFRA | 0.38312299 |
118 | SGK3 | 0.38015167 |
119 | TEC | 0.37380693 |
120 | TESK2 | 0.36471445 |
121 | SIK3 | 0.36460972 |
122 | PRKG2 | 0.35183310 |
123 | MAPKAPK2 | 0.32531699 |
124 | MAP3K8 | 0.30086906 |
125 | PRKD2 | 0.29725998 |
126 | MAP3K6 | 0.29544073 |
127 | IRAK1 | 0.28433390 |
128 | MAPK12 | 0.28015220 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 4.50738943 |
2 | * Lysosome_Homo sapiens_hsa04142 | 4.22532974 |
3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.85908852 |
4 | Other glycan degradation_Homo sapiens_hsa00511 | 3.21770524 |
5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.69611404 |
6 | Phagosome_Homo sapiens_hsa04145 | 2.49266872 |
7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.38894740 |
8 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.31702005 |
9 | Tuberculosis_Homo sapiens_hsa05152 | 2.26039332 |
10 | Pertussis_Homo sapiens_hsa05133 | 2.19517112 |
11 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.09803375 |
12 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.00189764 |
13 | Malaria_Homo sapiens_hsa05144 | 1.93512582 |
14 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.70599671 |
15 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.65968441 |
16 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.60306346 |
17 | Legionellosis_Homo sapiens_hsa05134 | 1.60117327 |
18 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.58011143 |
19 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.49090746 |
20 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.42178748 |
21 | Salmonella infection_Homo sapiens_hsa05132 | 1.42085644 |
22 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.41280298 |
23 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.39434321 |
24 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.34501256 |
25 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.28104787 |
26 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.27138848 |
27 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.22686452 |
28 | Measles_Homo sapiens_hsa05162 | 1.18012345 |
29 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.17427011 |
30 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.11930742 |
31 | Influenza A_Homo sapiens_hsa05164 | 1.11720212 |
32 | Shigellosis_Homo sapiens_hsa05131 | 1.07575667 |
33 | Bladder cancer_Homo sapiens_hsa05219 | 1.06954996 |
34 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.05258409 |
35 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.04591012 |
36 | Amoebiasis_Homo sapiens_hsa05146 | 1.02656207 |
37 | * Apoptosis_Homo sapiens_hsa04210 | 1.00898203 |
38 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.99021898 |
39 | * Antigen processing and presentation_Homo sapiens_hsa04612 | 0.97433768 |
40 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.96618173 |
41 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.94410259 |
42 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.91805580 |
43 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.91789049 |
44 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.90048350 |
45 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.89539161 |
46 | Prion diseases_Homo sapiens_hsa05020 | 0.88498005 |
47 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.85340026 |
48 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.83792603 |
49 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.82657012 |
50 | Endocytosis_Homo sapiens_hsa04144 | 0.82554776 |
51 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.82150623 |
52 | Asthma_Homo sapiens_hsa05310 | 0.80870867 |
53 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.80202787 |
54 | Hepatitis C_Homo sapiens_hsa05160 | 0.78924701 |
55 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.77056428 |
56 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.76991294 |
57 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.76565265 |
58 | Mineral absorption_Homo sapiens_hsa04978 | 0.73921808 |
59 | Hepatitis B_Homo sapiens_hsa05161 | 0.72268338 |
60 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.71737872 |
61 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.71354388 |
62 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.69176624 |
63 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.68542152 |
64 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.68478603 |
65 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.65531514 |
66 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.62430713 |
67 | Viral myocarditis_Homo sapiens_hsa05416 | 0.62316640 |
68 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.60832186 |
69 | Allograft rejection_Homo sapiens_hsa05330 | 0.60527838 |
70 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.59564183 |
71 | Platelet activation_Homo sapiens_hsa04611 | 0.59215987 |
72 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.58356114 |
73 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.57151551 |
74 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.56795123 |
75 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.56464166 |
76 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.54526513 |
77 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.54081617 |
78 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.52350398 |
79 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.52005433 |
80 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.51821543 |
81 | Galactose metabolism_Homo sapiens_hsa00052 | 0.51515385 |
82 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.50590782 |
83 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.49084319 |
84 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.49019367 |
85 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.47244080 |
86 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.44545571 |
87 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.42465379 |
88 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.41755282 |
89 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.40212849 |
90 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.37067454 |
91 | Focal adhesion_Homo sapiens_hsa04510 | 0.36179496 |
92 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.34795251 |
93 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.34415860 |
94 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.33573461 |
95 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.33177648 |
96 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.32754568 |
97 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.32676266 |
98 | Insulin resistance_Homo sapiens_hsa04931 | 0.31701307 |
99 | Glioma_Homo sapiens_hsa05214 | 0.31305407 |
100 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.31242019 |
101 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.30953938 |
102 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.30309405 |
103 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.29724479 |
104 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.29399029 |
105 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.29138548 |
106 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.27488193 |
107 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.27130953 |
108 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.24138191 |
109 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.23870903 |
110 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.23349139 |
111 | HTLV-I infection_Homo sapiens_hsa05166 | 0.20884133 |
112 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.20262601 |
113 | ABC transporters_Homo sapiens_hsa02010 | 0.20095203 |